Formulations Tri-Moxi®* – 0.6mL – Single Use Vial

Tri-Moxi®* – 0.6mL – Single Use Vial

(Triamcinolone acetonide/Moxifloxacin)

Dropless® formulations are available from our 503B outsourcing facility. More than 500,000 Dropless® formulations have been dispensed.

Click here to download the product insert for this formulation.

Classification Injectable
Sub-classification Suspension
Strength (Concentration) common dose* 15mg/1mg/mL
Size (Volume) 0.6mL (Single Use Vial)

Order today from our FDA-Registered Outsourcing Facility

Order your prescriptions now.

Order Now

*For professional use only. ImprimisRx® Pharmacy specializes in customizing medications to meet unique patient and practitioner needs. No compounded medication is reviewed by the FDA for safety or efficacy. ImprimisRx® does not compound copies of commercially available products. References available upon request.

Potential Ingredient Risks

Storage: Store at Room Temperature 20°C to 25°C (68°F to 77°F)

Auxiliary Labeling: Store upright in original bottle. Shake well before use.

Triamcinolone Acetonide

Possible Indications: Postoperative Ophthalmic Inflammation, Sympathetic Ophthalmia, Diffuse Posterior Uveitis, Allergic Corneal Margin Ulcer, Iritis and Keratitis, Optic Neuritis

Field Experience with Regard to Temporary Visual Impairment: Following intraocular administration of Triamcinolone Acetonide Suspension, it has been reported that visual acuity and “floaters” can take several hours; up to 36 hours to clear and in rare cases, up to 48 hours. Because of the nature of a suspension, which includes particles suspended in a vehicle, it is likely to affect the visual field for a period of time and consequently, patients should be appropriately counseled prior to use. The patient is encouraged to sit upright for 6 hours.

Possible Adverse Effects:Anaphylactoid Shock, Blindness, Cataract, Corneal Perforation, Cortical Cataract, Conjunctival Hemorrhage, Eye Pain, Infection, Irritation Pruritus, Abnormal Sensation in Eyes, Abnormal Sensory Symptoms, Edema, Bleeding at Injection Site, Glaucoma, Hypertension, Hypopyon, Increased Intraocular Pressure, Increased Lacrimation, Vitreous Detachment, Vitreous Opacity, Wound Healing Impairment

Potential Contraindications/Precautions: Infants, Lactation, Pregnancy, Cataract, Eye Infection, Increased Intraocular Pressure

Moxifloxacin HCl

Possible Indications: Bacterial Conjunctivitis

Possible Adverse Effects: Conjunctival Irritation, Fever Eye Irritation, Airway Obstruction, Anaphylaxis, Angioedema, Circulatory Shock, Dyspnea Facial Edema, Fungal Superinfection, Laryngeal Edema, Loss of Consciousness, Pharyngeal Edema, Pruritus, Superinfection, Urticaria, Pigment Dispersion Syndrome.

Potential Contraindications/Precautions: Infants, Lactation, Pregnancy.